विज्ञप्तियां उर्दू विज्ञप्तियां फोटो निमंत्रण लेख प्रत्यायन फीडबैक विज्ञप्तियां मंगाएं Search उन्नत खोज
RSS RSS
Quick Search
home Home
Releases Urdu Releases Photos Invitations Features Accreditation Feedback Subscribe Releases Advance Search
home  Printer friendly Page home  Email this page
English Release 3-March 2015
Date Month Year
  • President's Secretariat
  • President of India to inaugurate week long Festival of Innovations at Rashtrapati Bhavan on March 7, 2015

  • President of India’s message on the eve of National Day of Bulgaria
  • Dr. Baburam Bhattarai, former PM of Nepal calls on the President
  • Prime Minister's Office
  • Text of PM's reply to the debate on Motion of thanks to President’s Address in Rajya Sabha (Preliminary Transcript)
  • AYUSH
  • Increase in Demand for Medicinal Plants
  • Election Commission
  • Election Commission launches National Electoral Roll Purification and Authentication Programme (NERPAP) from today
  • Min for Develop. of North-East Region
  • Government to promote Northeast Study Center in JNU
  • Min of Agriculture
  • GIS System for Fisheries Sector
  • Employment in Agriculture
  • Use of Modern Equipments in Fruits Production
  • Formation of Multi State Cooperative Societies
  • Min of Chemicals and Fertilizers
  • Revival of Pharmaceutical Units
  • Indigenous Manufacturers Allowed Production of Fortified/ Coated Urea
  • Scheme Approved for Setting UP of Plastic Parks
  • Min of Civil Aviation
  • Thirtyfive Non-metro Airports Identified for Development
  • DGCA Sets up Unit to monitor Airfare
  • Min of Consumer Affairs, Food & Public Distribution
  • 100 Lakh MT wheat for Open Market Sale to contain prices
  • Steps Taken by the Government to contain prices of Essential Food Items
  • The Government targets 300 LMT wheat procurement for ensuing Rabi season
  • Measures to ensure remunerative prices for farmers
  • More than 242 lakh Families having highly Subsidised Foodgrains under the Antyodaya Anna Yojana
  • End-to-End Computerisation of PDS as a Mission Mode Project
  • Adequate foodgrains in the Central pool to meet the domestic requirement
  • Min of Corporate Affairs
  • CSR Activities in Metropolitan Cities of Maharashtra Question
  • Registration of Shell Companies
  • Need of Trained Professionals for CSR Activities
  • Records of Companies Under CSR Category
  • Min of Defence
  • Admiral Harry Harris Jr, Commander Pacific Fleet calls on Admiral Rk Dhowan, Chief of the Naval Staff
  • Intensifying Patrolling of Coastal Areas
  • Acquisitions of Submarines by Indian Navy
  • Quality of Products and Research made by DRDO
  • Appointment of Agents in Defence Deals
  • Participation of Finmeccanica in Defence Expo
  • Procurement of Stealth Fighter Aircraft
  • Restructure of BRO
  • Recruitment of Women in Armed Forces
  • Rehabilitation of Ex-Servicemen
  • Induction of LCA Tejas
  • Collision of Merchant Vessel with INS Cora
  • Stress on Investment Route in Defence Cooperation Agreements
  • Condition of Border Roads at Indo-China Border
  • Poor Conditions of Border Roads in Himachal Pradesh
  • Defence Procurement Deals Under Investigation
  • Defence Organisation Under the Purview of RTI
  • Min of Health and Family Welfare
  • Health Secretary Holds Review Meeting on H1N1
  • Recruitment Rules of Unani and Ayurvedic Pharmacists in CGHS Dispensaries
  • Registration of Slaughter Houses with FSSAI
  • Revision of National Health Policy
  • Side-Effects of Harmful Radiation from Mobile Phones and Towers
  • Effective Implementation of PNDT Act
  • Improvement of Service Conditions of Nurses
  • Compensation to Clinical Trial Volunteers
  • Formulary of Ayurvedic Medicines of CGHS
  • Diagnosing TB Under RNTCP
  • Strategy for Handling Genetically Transmitted Cancer Disease
  • Disposal and Recycling of Medical Wastes
  • Surrogacy Centres in the Country
  • Affordable Geriatric Healthcare
  • Avability of Oseltamivir to Treat Influenza a N1H1
  • Min of Home Affairs
  • False Cases
  • Crime Against People from North-East
  • Security of People from NER
  • Terror Camps in Bangladesh
  • Forensic Labs
  • Smuggling of Animals
  • Women Police Stations
  • Min of Law & Justice
  • Transfer of Shri Justice Raghvendra Singh Chauhan , Judge of Rajasthan High Court as Judge of Karnataka High Court
  • Appointment of Shri Justice Pradip Kumar Mohanty, Senior-Most Judge of Orissa High Court to Perform the Duties of the office of the Chief Justice of Orissa High Court
  • Min of Minority Affairs
  • Assistance to Women and Students of Minority Communities
  • Action Taken on The Report of Amitabh Kundu Committee
  • Min of Petroleum & Natural Gas
  • Global crude oil price of Indian Basket was US$ 59.95 per bbl on 02.03.2015
  • Min of Shipping
  • Agreement Signed for Export of Automobile Units through Kamarajar Port
  • Nitin Gadkari Launches ‘Shipping Samvad’
  • Min of Social Justice & Empowerment
  • Meeting of the Working Group on the Asian and Pacific Decade of Persons with Disabilities concludes toda
  • Training to Professionals for Care of Older Persons
  • Fund Allocation for OBCs
  • Improving the Condition of Older/Aged Persons
  • Pradhan Mantri Adarsh Gram Yojana
  • Financial Assistance for Scheduled Castes
  • 2.68 Crore Persons with Disabilities as per Census 2011
  • Institution for Deaf Students
  • Min of Urban Development
  • Two engineers of CPWD dismissed from service for corruption
  • Min of Youth Affairs and Sports
  • Sports Coaching Institutes in Rural Area
  • Youth Exchange Programme
  • Programmes through Nehru Yuva Kendras
  • Special Awards to Medal Winner in Sports Events
  • Funds for Development of Youth
  • National Service Scheme
  • Irregularities in Sports Bodies
  • Functioning of RGNIYD

Previous Date

 
Ministry of Health and Family Welfare11-March, 2011 15:34 IST
Banned Medicines
The Central Government has prohibited six drugs on the recommendations of the Expert Committee constituted by DTAB in view of the safety issues involved in the use of these drugs by a Gazette Notification dated 10.02.2011 with immediate effect. The names of these drugs along with the brief reasons for their ban are furnished below:

1. Nimesulide formulations in children below 12 years of age - Nimesulide containing products are not permitted in many countries in children under 12 years of age. The drug has been considered to be hepatotoxic and children are considered more susceptible to hepatotoxicity.
2. Cisapride and its formulations for human use - Use of this drug is reported to be associated with increased risk of serious cardiac arrhythmia.
3. Phenylpropanolamine and its formulations for human use - Use of this drug is associated with risk of hypertensive episodes like cardiac congestive failures and hemorrhagic strokes.
4. Human Placental Extract and its formulations for human use - There is no clear evidence of efficacy of this drug in most of the conditions and there are safety concerns like transmission of blood borne infections, immunoreactions and unwanted exposure to hormones associated with its use.
5. Sibutramine and its formulations for human use - Use of this drug is associated with increased risk of cardiovascular events such as heart attack and stroke.
6. R-Sibutramine and its formulations for human use - Use of this drug is associated with increased risk of cardiovascular events such as heart attack and stroke.
Apart from the aforementioned six drugs banned recently, the following drugs have been banned during the last three years:

1. Rosiglitazone, on 12th November, 2010 - Use of this drug is associated with increased risk of cardiovascular events such as congestive heart failure and myocardial infarction.
2. Rimonabant, on 11th December, 2009 - Use of this drug is associated with increased risk of psychiatric side effects.
3. Diclofenac and its formulations for animal use, on 4th July, 2008 - Extensive use of this drug in animals was leading to harmful effects on vultures. The vulture population was depleting as it was observed that vultures fed on carcass of animals treated with diclofenac were dying.

The decision to ban or withdraw a drug by the regulatory authorities is normally based on the risk assessment process, which is influenced by a number of factors such as disease pattern in a country, indications and dosages of the drug permitted, varying reactions of certain ethnic groups in a given population, availability of safer substitutes and overall safety profile of the drug. These conditions are different for different countries. It is for this reason that a drug banned / restricted in one country may continue to be marketed in other countries. There is a well laid out mechanism in India to review the status of the drug formulations as and when any serious adverse event is reported in the International journals, WHO Newsletters or when a drug formulation is reported to have been banned / withdrawn in some countries. The use of the drug, so reported, is assessed in consultation with the expert committees set up for the purpose, based on available technical information, benefit-risk ratio, local needs and availability of safer alternatives etc. The Central Government prohibit manufacture and sale of drugs in the country under Section 26A of the Drugs and Cosmetics Act, 1940.

This information was given by Minister of Health & Family Welfare Sh. Ghulam Nabi Azad in reply to a question in the Lok Sabha today.

*****


SBS/RS
(Release ID :70841)

Web Ratana This site is winner of Platinum Icon for 'Outstanding Web Content' Web Ratna Award'09 presented in April 2010
Site is designed and hosted by National Informatics Centre (NIC),Information is provided and updated by Press Information Bureau
"A" - Wing, Shastri Bhawan, Dr. Rajendra Prasad Road, New Delhi - 110 001 Phone 23389338
Content Manager : Ms. Ira Joshi, ADG(IT).
Go Top Top

उपयोग संबंधी शर्तें स्वोत्वाधिकार नीति गोपनीयता संबंधी नीति हाइपरलिंकिंग नीति Terms of Use Copyright Policy Privacy Policy Hyperlinking Policy